down arrow

Anuh Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
172.50
4.95 (2.95%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.87 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

170.50174.05

52 Week

148.05261.00
Valuation
Technical
Day's Volume

CASH

13.87 k (-74.01%) Volume

Shareholding (Sep 2024)

FII

0.02%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

69.92%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 14.56% and Operating profit at 16.15% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 864 Cr (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.49%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

16.58%

stock-summary
Price to Book

2.77

Revenue and Profits (1 Year):
Net Sales:
160 Cr
(Quarterly Results - Dec 2024)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.49%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.51%
0%
-16.51%
1 Year
-26.11%
1.01%
-25.1%
2 Years
100.51%
5.05%
105.56%
3 Years
60.91%
6.90%
67.81%
4 Years
45.88%
5.04%
50.92%
5 Years
117.73%
9.77%
127.5%

Latest dividend: 2.5 per share ex-dividend date: Aug-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.56%
EBIT Growth (5y)
16.15%
EBIT to Interest (avg)
37.64
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.96
Tax Ratio
20.79%
Dividend Payout Ratio
20.86%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
19.39%
ROE (avg)
15.56%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
33
Price to Book Value
2.77
EV to EBIT
15.06
EV to EBITDA
13.05
EV to Capital Employed
3.02
EV to Sales
1.28
PEG Ratio
NA
Dividend Yield
1.49%
ROCE (Latest)
23.53%
ROE (Latest)
16.58%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.02%)

Promoter with highest holding

Bharti Bipin Shah (19.43%)

Highest Public shareholder

None

Individual Investors Holdings

26.27%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -3.88% vs 20.33% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -31.25% vs 58.15% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "159.51",
          "val2": "165.95",
          "chgp": "-3.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.78",
          "val2": "16.87",
          "chgp": "-12.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.28",
          "val2": "0.16",
          "chgp": "75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.34",
          "val2": "15.04",
          "chgp": "-31.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.27%",
          "val2": "10.17%",
          "chgp": "-0.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -2.30% vs 34.37% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -4.06% vs 48.35% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "303.86",
          "val2": "311.01",
          "chgp": "-2.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.44",
          "val2": "31.93",
          "chgp": "-14.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.31",
          "val2": "0.11",
          "chgp": "181.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "24.55",
          "val2": "25.59",
          "chgp": "-4.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.03%",
          "val2": "10.27%",
          "chgp": "-1.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -4.09% vs 30.51% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -21.95% vs 68.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "463.37",
          "val2": "483.11",
          "chgp": "-4.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.22",
          "val2": "55.92",
          "chgp": "-24.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.59",
          "val2": "0.25",
          "chgp": "136.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "34.89",
          "val2": "44.70",
          "chgp": "-21.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.11%",
          "val2": "11.58%",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 66.00% vs 18.39% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "647.00",
          "val2": "527.49",
          "chgp": "22.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "75.14",
          "val2": "51.28",
          "chgp": "46.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.22",
          "chgp": "59.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "60.06",
          "val2": "36.18",
          "chgp": "66.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.61%",
          "val2": "9.72%",
          "chgp": "1.89%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
159.51
165.95
-3.88%
Operating Profit (PBDIT) excl Other Income
14.78
16.87
-12.39%
Interest
0.28
0.16
75.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.34
15.04
-31.25%
Operating Profit Margin (Excl OI)
9.27%
10.17%
-0.90%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -3.88% vs 20.33% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -31.25% vs 58.15% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
303.86
311.01
-2.30%
Operating Profit (PBDIT) excl Other Income
27.44
31.93
-14.06%
Interest
0.31
0.11
181.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
24.55
25.59
-4.06%
Operating Profit Margin (Excl OI)
9.03%
10.27%
-1.24%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -2.30% vs 34.37% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -4.06% vs 48.35% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
463.37
483.11
-4.09%
Operating Profit (PBDIT) excl Other Income
42.22
55.92
-24.50%
Interest
0.59
0.25
136.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
34.89
44.70
-21.95%
Operating Profit Margin (Excl OI)
9.11%
11.58%
-2.47%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -4.09% vs 30.51% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -21.95% vs 68.30% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
647.00
527.49
22.66%
Operating Profit (PBDIT) excl Other Income
75.14
51.28
46.53%
Interest
0.35
0.22
59.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
60.06
36.18
66.00%
Operating Profit Margin (Excl OI)
11.61%
9.72%
1.89%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 66.00% vs 18.39% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Anuh Pharma Ltd stock-summary
stock-summary
Anuh Pharma Ltd
Micro Cap
Pharmaceuticals & Drugs
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of "Bulk drugs and chemicals Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group. Anuh Pharma Ltd was incorporated on February 19, 1960.
Company Coordinates stock-summary
Company Details
3-A Shivsagar Estate, North Wing Dr A B Road Worli Mumbai Maharashtra : 400018
stock-summary
Tel: 91-22-6622 7575
stock-summary
http://www.anuhpharma.com
stock-summary
anuh@sk1932.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."